Review
[Hormonal contraception and postmenopausal estrogen substitution in relation to malignant tumors]
[Article in
German]
Affiliations
- PMID: 2264417
Item in Clipboard
Review
[Hormonal contraception and postmenopausal estrogen substitution in relation to malignant tumors]
[Article in
German]
Zentralbl Gynakol.
1990.
Abstract
The concept of contraindication of estrogens in patients with endometrial, ovarian and cervical cancer has to be corrected. The German Society of Endocrinology recommend estrogens replacement in cervical, ovarian and vulva carcinoma. Breast and endometrial cancer are relative contraindications. Review of the literature with 104 citations.
Similar articles
-
[Cancer risk under hormone therapy].Ther Umsch. 1994 Nov;51(11):755-66. Ther Umsch. 1994. PMID: 7839334 Review. German.
-
[Do sex steroids cause breast and genital cancers? Epidemiologic data--the current status (July 1993)].Geburtshilfe Frauenheilkd. 1993 Oct;53(10):657-66. doi: 10.1055/s-2007-1023605. Geburtshilfe Frauenheilkd. 1993. PMID: 8270146 Review. German.
-
[Use of hormone-replacement therapy and steroid contraceptives in menopause as an oncological and epidemiological problem: is it a risk and/or benefit?].Vopr Onkol. 2005;51(6):636-46. Vopr Onkol. 2005. PMID: 17037027 Review. Russian. No abstract available.
-
[Hormonal replacement therapy and oral contraception. Risk of induction or reactivation of gynecologic malignancies].Gynakol Geburtshilfliche Rundsch. 1995;35(2):72-8. doi: 10.1159/000272488. Gynakol Geburtshilfliche Rundsch. 1995. PMID: 7620385 Review. German.
-
[Postmenopausal hormone replacement therapy and cancer of the female genitalia and breast].Ned Tijdschr Geneeskd. 1997 Feb 22;141(8):368-72. Ned Tijdschr Geneeskd. 1997. PMID: 9157296 Review. Dutch.